phase readout
saveNCT06307093: Study Comparing the Pharmacokinetics, Safety, and Efficacy of RPH-075 and Keytruda® in Patients With Malignant Neoplasms
COMPLETEDupdated 2m ago
community read0 votes
Sponsor: R-Pharm. Phase: PHASE1. Conditions: Skin Melanoma, Squamous Non-small-cell Lung Cancer, Head and Neck Squamous Cell Carcinoma
view source ↗
comments(0)
5-min edit window · permanent after that